← Leaderboards
Eugene M. Oltz
Vanderbilt University
$20,457,685
Attributed
$28,055,677
Total exposure
25
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.9M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$38,433,933 · 26
By mechanism
R01$18,826,974 · 8
U54$13,165,182 · 6
R21$2,682,072 · 7
R37$2,313,487 · 1
R56$621,424 · 1
P01$570,107 · 1
Top collaborators
- Jacqueline E. Payton10 shared
- Marco Colonna9 shared
- Ann Scheck Mcalearney6 shared
- Ashish Raman Panchal6 shared
- Linda J. Saif6 shared
- Craig H. Bassing5 shared
- Maksym Artomov2 shared
- Barry P Sleckman2 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Scott Hiebert$33,340,607
- Frederick R Haselton$7,154,000
- Roy Zent$14,704,410
- James Ward Thomas$11,948,664
- James M May$14,782,027
Others in their field
Top investigators on “Chromatin”
- Michael P Snyder · Yale University$98,050,605
- Bing Ren · Ludwig Institute For Cancer Research$76,818,585
- John A Stamatoyannopoulos · Regulome Corporation$56,022,526
- Bradley E Bernstein · Brigham And Women'S Hospital$44,846,223
- Eric J Nestler · Icahn School Of Medicine At Mount Sinai$42,440,927
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$40,714,772
Research focus
ChromatinGene ExpressionElementsGenesInsightLymphocyteProgramsEnhancersResponseBaseMediatingGenomeAntigen ReceptorsEpigenetic ProcessGenetic TranscriptionReceptor GeneCellsGeneticMolecularTissuesLeadPatternLinkCohort
Grant awards (74)
Cis-Regulatory Circuits for ILC Function and Plasticity$750,844
R01 · FY2025 · AI
TOPOLOGICAL MECHANISMS OF DNA BREAK REPAIR IN LYMPHOCYTES$452,849
R37 · FY2025 · AI · contact PI
Generation of an ILC3-specific Cre driver in mice$76,388
R03 · FY2025 · AI · contact PI
Center for serological testing to improve outcomes from pandemic COVID-19 (STOP-COVID)$846,715
U54 · FY2024 · CA · contact PI
TOPOLOGICAL MECHANISMS OF DNA BREAK REPAIR IN LYMPHOCYTES$457,909
R37 · FY2024 · AI · contact PI
Generation of an ILC3-specific Cre driver in mice$78,750
R03 · FY2024 · AI · contact PI
Center for Serological Testing to Improve Outcomes from Pandemic COVID-19 (STOP-COVID)$3,143,795
U54 · FY2023 · CA · contact PI
TOPOLOGICAL MECHANISMS OF DNA BREAK REPAIR IN LYMPHOCYTES$462,872
R37 · FY2023 · AI · contact PI
Center for Serological Testing to Improve Outcomes from Pandemic COVID-19 (STOP-COVID)$1,995,256
U54 · FY2022 · CA · contact PI
CIS-REGULATORY CIRCUITS FOR ILC FUNCTION AND PLASTICITY$639,023
R01 · FY2022 · AI
TOPOLOGICAL MECHANISMS OF DNA BREAK REPAIR IN LYMPHOCYTES$467,732
R37 · FY2022 · AI · contact PI
Project 1: COVID-19 prevalence, transmission, and protection in extended first responder cohorts$452,646
U54 · FY2022 · CA · contact PI
Center for Serological Testing to Improve Outcomes from Pandemic COVID-19 (STOP-COVID)$439,659
U54 · FY2022 · CA · contact PI
Admin-Core-001$439,659
U54 · FY2022 · CA · contact PI
Core B: Testing and Biorepository$290,380
U54 · FY2022 · CA · contact PI
Topological Control of Antigen Receptor Loci during Lymphocyte Development$731,023
R01 · FY2021 · AI
CIS-REGULATORY CIRCUITS FOR ILC FUNCTION AND PLASTICITY$650,048
R01 · FY2021 · AI
TOPOLOGICAL MECHANISMS OF DNA BREAK REPAIR IN LYMPHOCYTES$472,125
R37 · FY2021 · AI · contact PI
Center for Serological Testing to Improve Outcomes from Pandemic COVID-19 (STOP-COVID)$3,952,831
U54 · FY2020 · CA · contact PI
Core B: Testing and Biorepository$842,780
U54 · FY2020 · CA · contact PI
Project 1: COVID-19 prevalence, transmission, and protection in extended first responder cohorts$761,461
U54 · FY2020 · CA · contact PI
Topological Control of Antigen Receptor Loci during Lymphocyte Development$726,998
R01 · FY2020 · AI
CIS-REGULATORY CIRCUITS FOR ILC FUNCTION AND PLASTICITY$650,048
R01 · FY2020 · AI
Topological Control of Antigen Receptor Loci during Lymphocyte Development$722,423
R01 · FY2019 · AI
CIS-REGULATORY CIRCUITS FOR ILC FUNCTION AND PLASTICITY$686,003
R01 · FY2019 · AI
Topological Mechanisms of DNA Break Repair in Lymphocytes$390,000
R01 · FY2019 · AI · contact PI
SEQUENCE-SPECIFIC CHROMATIN MODIFIERS; NOVEL PROTEIN THERAPEUTICS FOR B CELL LYMPHOMA$338,378
R01 · FY2019 · CA
Topological Control of Antigen Receptor Loci during Lymphocyte Development$786,193
R01 · FY2018 · AI
CIS-REGULATORY CIRCUITS FOR ILC FUNCTION AND PLASTICITY$654,900
R01 · FY2018 · AI
TOPOLOGICAL MECHANISMS OF DNA BREAK REPAIR IN LYMPHOCYTES$381,250
R01 · FY2018 · AI · contact PI
SEQUENCE-SPECIFIC CHROMATIN MODIFIERS; NOVEL PROTEIN THERAPEUTICS FOR B CELL LYMPHOMA$348,844
R01 · FY2018 · CA
Topological Control of Antigen Receptor Loci during Lymphocyte Development$817,855
R01 · FY2017 · AI
Cis-Regulatory Circuits for ILC Function and Plasticity$621,424
R56 · FY2017 · AI · contact PI
TOPOLOGICAL MECHANISMS OF DNA BREAK REPAIR IN LYMPHOCYTES$381,250
R01 · FY2017 · AI · contact PI
SEQUENCE-SPECIFIC CHROMATIN MODIFIERS; NOVEL PROTEIN THERAPEUTICS FOR B CELL LYMPHOMA$348,844
R01 · FY2017 · CA
REGULATION OF OF GENOME ARCHITECTURE IN LYMPHOCYTES: OPPOSING TETHER AND BOUNDARY FUNCTIONS$228,750
R21 · FY2017 · AI · contact PI
TOPOLOGICAL MECHANISMS OF DNA BREAK REPAIR IN LYMPHOCYTES$381,250
R01 · FY2016 · AI · contact PI
SEQUENCE-SPECIFIC CHROMATIN MODIFIERS; NOVEL PROTEIN THERAPEUTICS FOR B CELL LYMPHOMA$348,844
R01 · FY2016 · CA
CHROMATIN-BASED DISCOVERY AND FUNCTION OF NOVEL TCR REGULATORY ELEMENTS$190,625
R21 · FY2016 · AI · contact PI
REGULATION OF OF GENOME ARCHITECTURE IN LYMPHOCYTES: OPPOSING TETHER AND BOUNDARY FUNCTIONS$190,625
R21 · FY2016 · AI · contact PI
CHROMATIN-BASED DISCOVERY OF ILC GENE REGULATORY CIRCUITS$190,625
R21 · FY2016 · AI · contact PI
TOPOLOGICAL MECHANISMS OF DNA BREAK REPAIR IN LYMPHOCYTES$381,250
R01 · FY2015 · AI · contact PI
SEQUENCE-SPECIFIC CHROMATIN MODIFIERS; NOVEL PROTEIN THERAPEUTICS FOR B CELL LYMPHOMA$348,844
R01 · FY2015 · CA
CHROMATIN-BASED DISCOVERY AND FUNCTION OF NOVEL TCR REGULATORY ELEMENTS$228,750
R21 · FY2015 · AI · contact PI
CHROMATIN-BASED DISCOVERY OF ILC GENE REGULATORY CIRCUITS$228,750
R21 · FY2015 · AI · contact PI
TARGETING EPIGENOMIC SIGNATURES IN NON-HODGKIN LYMPHOMA FOR NOVEL THERAPEUTICS$594,657
R01 · FY2014 · CA · contact PI
TARGETING EPIGENOMIC SIGNATURES IN NON-HODGKIN LYMPHOMA FOR NOVEL THERAPEUTICS$585,023
R01 · FY2013 · CA · contact PI
Accessibility Control of Antigen Receptor Gene Assembly$350,092
R01 · FY2013 · AI · contact PI
TARGETING EPIGENOMIC SIGNATURES IN NON-HODGKIN LYMPHOMA FOR NOVEL THERAPEUTICS$635,460
R01 · FY2012 · CA · contact PI
Accessibility Control of Antigen Receptor Gene Assembly$372,438
R01 · FY2012 · AI · contact PI
LOCALIZED REVISION OF EPIGENETIC LANDSCAPES INDUCED BY DNA DOUBLE-STRAND BREAKS$190,000
R21 · FY2012 · ES
TARGETING EPIGENOMIC SIGNATURES IN NON-HODGKIN LYMPHOMA FOR NOVEL THERAPEUTICS$638,948
R01 · FY2011 · CA · contact PI
Accessibility Control of Antigen Receptor Gene Assembly$372,438
R01 · FY2011 · AI · contact PI
LOCALIZED REVISION OF EPIGENETIC LANDSCAPES INDUCED BY DNA DOUBLE-STRAND BREAKS$228,000
R21 · FY2011 · ES
TARGETING EPIGENOMIC SIGNATURES IN NON-HODGKIN LYMPHOMA FOR NOVEL THERAPEUTICS$655,122
R01 · FY2010 · CA · contact PI
Accessibility Control of Antigen Receptor Gene Assembly$376,200
R01 · FY2010 · AI · contact PI
Long-Range Genetic and Epigenetic Control of Igh Gene Assembly$228,000
R21 · FY2010 · AI · contact PI
Long-Range Genetic and Epigenetic Control of Tcrb Gene Assembly$225,720
R21 · FY2010 · AI · contact PI
Accessibility Control of Antigen Receptor Gene Assembly$208,750
R01 · FY2009 · AI · contact PI
Long-Range Genetic and Epigenetic Control of Igh Gene Assembly$190,000
R21 · FY2009 · AI · contact PI
Long-Range Genetic and Epigenetic Control of Tcrb Gene Assembly$190,000
R21 · FY2009 · AI · contact PI
Accessibility Control of Antigen Receptor Gene Assembly$174,800
R01 · FY2009 · AI · contact PI
Accessibilty Control of Antigen Receptor Gene Assembly$331,119
R01 · FY2008 · CA · contact PI
Accessibilty Control of Antigen Receptor Gene Assembly$339,505
R01 · FY2007 · CA · contact PI
Accessibilty Control of Antigen Receptor Gene Assembly$302,276
R01 · FY2006 · CA · contact PI
B Lymphocyte based functional genomics of inflammation$301,420
P01 · FY2006 · HL · contact PI
Accessibilty Control of Antigen Receptor Gene Assembly$309,550
R01 · FY2005 · CA
Accessibilty Control of Antigen Receptor Gene Assembly$309,550
R01 · FY2004 · CA
MOLECULAR CONTROL OF ANTIGEN RECEPTOR GENE ASSEMBLY$340,219
R01 · FY2002 · AI
B Lymphocyte based functional genomics of inflammation$268,687
P01 · FY2002 · HL
MOLECULAR CONTROL OF ANTIGEN RECEPTOR GENE ASSEMBLY$340,875
R01 · FY2001 · AI
MOLECULAR CONTROL OF ANTIGEN RECEPTOR GENE ASSEMBLY$172,227
R21 · FY2000 · AI
MOLECULAR CONTROL OF ANTIGEN RECEPTOR GENE ASSEMBLY$125,840
R01 · FY2000 · AI
MOLECULAR CONTROL OF ANTIGEN RECEPTOR GENE ASSEMBLY$99,549
K02 · FY2000 · AI